Roche’s emicizumab cleared for early access in the UK

5th January 2018 Uncategorised 0

Roche’s emicizumab in being included in the UK’s Early Access to Medicines Scheme for routine prophylaxis of bleeding episodes in patients with haemophilia A with factor VIII inhibitors.

More: Roche’s emicizumab cleared for early access in the UK
Source: News